ruxolitinib,navtemadlin
incyte,kartos therapeutics,novartis
['navtemadlin', 'rux,(-crux),(-trux),(-deruxtecan)', 'ruxolitinib', 'rux,(-crux),(-trux)']
fantastic presentation #johnmascarenhas on update of #navtemadlin added to suboptimal responders to #ruxolitinib in #mf. #eha23. exciting data &amp; can't wait for longer followup, including effect on marrow fibrosis changes . moving deeper in myelofibrosis 
Leukemia doc interested in #leukemia, #MPN, #hematology. Tweets= my opinion.